Currrent status and research strategies in tuberculosis drug development
Dover, Lynn G. and Coxon, Geoffrey (2011) Currrent status and research strategies in tuberculosis drug development. Journal of Medicinal Chemistry, 54 (18). 6157–6165. ISSN 0022-2623 (https://doi.org/10.1021/jm200305q)
Full text not available in this repository.Request a copyAbstract
In this Miniperspective we broadly cover the recent developments and strategies that are being adopted globally in the battle to urgently discover and develop new drugs to treat tuberculosis (TB). It highlights the impact and outcomes of recent nongovernment organizations (NGO) and academic research consortia that have made a significant impact in recent years in the field, providing the reader with an insight into the overall status of TB drug discovery and development while illustrating the current strategies and directions that are currently being adopted to find new drugs to control the disease.
ORCID iDs
Dover, Lynn G. and Coxon, Geoffrey ORCID: https://orcid.org/0000-0002-3541-5236;-
-
Item type: Article ID code: 38938 Dates: DateEvent2011Published8 August 2011Published OnlineSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 04 Apr 2012 10:26 Last modified: 11 Nov 2024 10:06 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/38938